Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 4

High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine

Pages
292–293
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Özet

-

🔖

Cite This Article

CANALE, M. L., CAMERİNİ, A., MAGNACCA, M., MEGLİO, J. D., LİLLİ, A., DONATİ, S., AMOROSO, D., CASOLO, G. (2018). High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 4, 292–293. https://ajindex.com/articles/365324

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Lin X, Li Q, Wang YJ, Ju YW, Chi ZQ, Wang MW, et al. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor κB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem J 2007; 406: 215-21. [CrossRef] Doroshow JH. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res 1983; 43: 460-72.
  2. He SF, Jin SY, Wu H, Wang B, Wu YX, Zhang SJ, et al. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt. Toxicol Appl Pharmacol 2015; 288: 349-58. [CrossRef] Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI, Dehpour AR. Morphine is protective against doxorubicininduced cardiotoxicity in rat. Toxicology 2008; 243: 96-104. [CrossRef] Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al; ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2768-2801. [CrossRef]